-
Investigating the Role of Lysosomal Biomarker ATP13A2 in the Pathogenesis of Parkinson’s Disease
… of a variety of neurodegenerative diseases, including PD, multiple system atrophy and progressive supranuclear palsy. Additionally, we …
-
A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: towards improving experimental reproducibility in α-synuclein research
January 11, 2020
… synucleinopathies, including Parkinson's disease (PD), multiple system atrophy and dementia with Lewy bodies (DLB). However, the …
-
Identifying Protein Changes Associated with Parkinson’s Disease: Proteomics Public Data Compilation
… Parkinson’s disease (PD), Lewy body dementia (LBD) and multiple system atrophy (MSA). Cataloguing these pathological protein …
-
SUPPLEMENT: Rescreening of the MJFF Compound Library to Identify Molecules that Can be Used to Monitor Alpha-synuclein
… sections taken from the brains of people with PD and with multiple system atrophy (MSA) using the tritium-labeled versions of BF3620 …
-
Parkinson’s Disease Vaccine Treatment Approach Awarded $8M
April 29, 2014
… developing vaccines against Parkinson’s disease (PD) and multiple system atrophy (MSA). The Michael J. Fox Foundation granted AFFiRiS …
-
Metabolomic Analysis of Parkinsonian Disorders
… confused with PD (progressive supranuclear palsy and multiple system atrophy) will also be studied for constituents in samples of …